Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. [electronic resource]
Producer: 20210813Description: 487-500 p. digitalISSN:- 1557-1904
- Animals
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Doxorubicin -- administration & dosage
- Drug Compounding
- Drug Delivery Systems
- Extracellular Vesicles -- chemistry
- Female
- Humans
- Liposomes
- Lung Neoplasms -- drug therapy
- Macrophages -- chemistry
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Nanoparticles
- Paclitaxel -- administration & dosage
- Triple Negative Breast Neoplasms -- drug therapy
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.